Ubume be-Remeron (iMirtazapine) I-Atypical Antidepressant

I-Remeron ineMiphumo emininzi yamandla angasetyenziswayo

I-Remeron (i-mirtazapine) i-anti-depressant engamakhemikhali engahambelani namanye ama-antidepressants, ekwahlula njenge-anti-depressant atypical. I-FDA ivunyiwe ukuphatha ingxaki enkulu yokudandatheka kubantu abadala, kodwa ingadangali kubantu abaneengxaki zokugula ngengqondo.

Indlela iMeronon isebenza ngayo

I-Remeron isebenza ngokwandisa ukukhululwa kwe- serotonin kunye ne- norepinephrine , iikhemikhali ezimbini zobuchopho ezihlobene nokudandatheka.

Iphinde ibophezele kwiimbali ze-histamine, mhlawumbi kutheni le myeza ibangela ukuba abantu abaninzi bazive bekhathele. Ngexesha elifanayo, alubopheli kakuhle kuma-receptors ezinxulumene nemiphumo emibi engxaki nakwezinye iintlobo ze-anti-depressants, kubandakanywa ne-sex driving drive, i-nausea, ukwesaba, intloko, ukulala, nokudida.

I-Remeron ifumaneka kwifomu yethebhulethi kumlinganiselo we-15, 30 ne-45 milligram. Kwakhona kufumaneka kumayeza afanayo njengeRemeron SolTabsĀ®, imithi yomlomo ephazamisayo ngolwimi kwimizuzu embalwa. Umlomo we-Generic Remeron ufumaneka kwi-7.5 milligrams.

I-Remeron Iimpawu zokuQaphela kunye neZingcebiso

Njengazo zonke ezinye izidakamizwa, uRemeron uthatha isilumkiso sebhokisi emnyama ngokumalunga nomngcipheko wokuzibulala nokuzibulala kubantwana, abaselula kunye nabaselula.

I-Remeron nayo inomngcipheko omncinci wokubangela i-agranulocytosis, imeko apho inani le-white cell cells liyancipha kwaye umzimba unzima ukulwa nezifo.

Ezinye iingozi ezinobungozi ziquka:

Kubalulekile ukuba ufune unyango ngokukhawuleza ukuba ufumana naziphi na iziphumo ezibi zilapha ngasentla.

Ukongezelela, ubuthongo luyinto eqhelekileyo kunye nefuthe elibi kakhulu leRemeron, yikho kutheni kuthathwa ngexesha lokulala. Ngenxa yolu hlobo lwenkqubela, i-Remeron inokuchaphazela ukucinga, isigwebo kunye nezakhono zamandla. Oku kuthetha ukuqhuba, ukusebenzisa imishini kunye nokwenza eminye imisebenzi omele uyiqaphele ayilunyanzelwanga de uze wazi ukuba i-Remeron ikuchaphazela njani.

Utywala lunokuyingozi ngakumbi ukuhlambalaza kunye nokuxakeka kwabantu abathile, ngoko uyacetyiswa ukuba ungaphuzi kotywala ngeli thuba. Ukwacetyiswa ukuba ugweme i- benzodiazepines , edlalwa ngamanye amaxesha ukuxhalaba, ukuthatha, kunye nokulala ngenxa yokuba bangakwazi ukwandisa le miphumo.

Iimpembelelo eziqhelekileyo zeRemeron

Ezi ziphumo zecala eziqhelekileyo zingase zihambe ngexesha, kodwa ukuba azinako okanye zixhala, qiniseka ukuba ugqirha ugqirha wakho. Ziquka:

Ngokumalunga nokufumana isisindo somzimba kunye nokunyuka kwesondlo, kwiilingo ezilawulwayo, ukwanda kwondlo kwafumene ama-17 eepesenti zezigulane, kwaye i-7.5 ekhulwini yezigulane zithi zifumana ubuncinane ubuncinane be-7 ekhulwini lomzimba wabo. Ubungqina bokuba u-Anecdotal bubonisa ukuba ukufumana ubunzima obukhulu kunokwenzeka. I-Remeron inokunyusa i-cholesterol yegazi kunye namazinga e-triglyceride.

ILizwi

I-caveat enomdla malunga neRemeron kukuba i-sedation eyenzekayo yenzelwe ukwanda kwinqanaba eliphantsi. Ngamanye amazwi, ukuguqulwa kuvelele kakhulu kubantu kwi-dose ye-15mg ngosuku ngaphezu kwee-30mg okanye ngaphezulu ngosuku.

Yingakho abanye oogqirha baqala umntu kwi-dose ephezulu ye-30mg (ukunciphisa umonakalo wokuguqula).

Njengoko kunjalo, kubalulekile ukuba uthathe u-Remeron kuphela phantsi kolawulo lugqirha wakho kwaye ungaguquli umthamo okanye unqande imithi yakho. Qiniseka ukuxelela ugqirha wakho kwiingxaki zempilo zakho, ingakumbi nayiphi na intliziyo, isibindi, okanye iinjongo, iimeko, njengoko oku kunokuchaphazela ukusebenzisa kwakho okanye umlinganiselo weyeza.

Imithombo:

> FDA. (2009). Isikhokelo seMithi : Remeron .

> Hirsch M, Birnbaum RJ. (Septemba 2016). I-anti-depressant i-Atypical: i-Pharmacology, ulawulo kunye nemiphumo emibi. Ku: U-UpToDate, uRoy-Byrne PP (Ed), UpToDate, Waltham, MA.